Bridges Investment Management Inc
Source: SEC Form 13F · as of Mar 2026Bridges Investment Management Inc holds 17 biotech & pharma companies tracked by BioSniper, totaling $208.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$208.6M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 186,093 | $40.5M |
| AMGNAMGEN INC | 87,581 | $30.8M |
| ZTSZoetis Inc. | 248,809 | $29.4M |
| ABTABBOTT LABORATORIES | 277,089 | $28.4M |
| LLYELI LILLY & Co | 24,956 | $23.0M |
| JNJJOHNSON & JOHNSON | 75,302 | $18.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 67,251 | $18.2M |
| PMPhilip Morris International Inc | 46,414 | $7.7M |
| MRKMerck & Co., Inc. | 55,851 | $6.7M |
| IQVIQVIA Holdings Inc. | 8,914 | $1.5M |
| PFEPFIZER INC | 46,831 | $1.3M |
| BMYBRISTOL MYERS SQUIBB CO | 12,749 | $773K |
| CORCencora Inc. | 2,357 | $740K |
| SUNSUNSET ISLAND GROUP | 4,927 | $320K |
| NVONovo Nordisk A/S | 7,311 | $269K |
| PBHPrestige Consumer Healthcare Inc. | 4,527 | $268K |
| IDXXIDEXX LABORATORIES INC /DE | 451 | $253K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.